Previous 10 | Next 10 |
2023-12-30 09:05:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-12 12:03:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ESSA Pharma (NASDAQ: EPIX ) just reported results for the fourth quarter of 2023. ESSA Pharma reported earnings per share of -12 cents. This was above the analyst estimate...
2023-12-12 07:25:31 ET More on ESSA Pharma ESSA Pharma: Unique N-Terminal Domain Approach Might Hinder mCRPC Resistance Seeking Alpha’s Quant Rating on ESSA Pharma Historical earnings data for ESSA Pharma Financial information for ESSA Pharma F...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023 Canada NewsWire Phase 1 dose escalation complete for masofaniten (EPI-7386)/enzalutamide combination study in patients with mCRPC; compelling safety ...
Axcella Health Inc. (AXLA) is expected to report for Q3 2023 Telekom Malaysia Bhd (MYTEF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 Scryb Inc Com (SCYRF) is expected to report for Q4 2023 BHP Group Ltd. (BHP) is expected...
ESSA Pharma Inc. (EPIX) is expected to report $-0.23 for Q4 2023
2023-11-24 10:41:14 ET More on 3D Systems 3D Systems Corporation (DDD) Q3 2023 Earnings Call Transcript 3D Systems: No Relief In Sight For further details see: ESSA Pharma director Franklin Berger buys common shares worth ~$133.3K
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Nov. 21, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmac...
2023-11-17 10:41:27 ET More on ESSA Pharma ESSA Pharma: Unique N-Terminal Domain Approach Might Hinder mCRPC Resistance Seeking Alpha’s Quant Rating on ESSA Pharma For further details see: ESSA Pharma says Berger bought 76.5K shares in co
ESSA Pharma to Present at the Jefferies London Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO , Calif. and VANCOUVER, Canada , Nov. 8, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutica...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma Inc. Company Name:
EPIX Stock Symbol:
NASDAQ Market:
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire SOUTH SAN FRANCISCO , Calif. and VANCOUVER, BC , April 9, 2...
2024-03-27 01:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-14 02:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...